{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:58:05Z","timestamp":1791233885231,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung Technologie und Raumfahrt Informationstechnikzentrum Bund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.eclinm.2026.103988","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:50:08Z","timestamp":1779472208000},"page":"103988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Next-step treatment for schizophrenia non-responsive to antipsychotics: a systematic review and network meta-analysis"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1317-0220","authenticated-orcid":false,"given":"Yuki","family":"Furukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1431-3473","authenticated-orcid":false,"given":"Nurul Husna","family":"Salahuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7186-6018","authenticated-orcid":false,"given":"Yaohui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Pinioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Milosavlijevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8264-2039","authenticated-orcid":false,"given":"Spyridon","family":"Siafis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schneider-Thoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrto","family":"Samara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bighelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4934-4352","authenticated-orcid":false,"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.103988_bib2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/schbul\/sby095","article-title":"How many patients with schizophrenia do not respond to antipsychotic drugs in the short term? An analysis based on individual patient data from randomized controlled trials","volume":"45","author":"Samara","year":"2019","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.eclinm.2026.103988_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103291","article-title":"Efficacy and tolerability of pharmacological interventions for schizophrenia non-responsive to prior treatment: a systematic review and network meta-analysis","volume":"84","author":"Samara","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.eclinm.2026.103988_bib5","first-page":"CD011883","article-title":"Increasing antipsychotic dose for non response in schizophrenia","volume":"2018","author":"Samara","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eclinm.2026.103988_bib6","first-page":"CD011885","article-title":"Switching antipsychotics versus continued current treatment in people with non-responsive schizophrenia","volume":"2025","author":"Samara","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eclinm.2026.103988_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2215-0366(24)00136-6","article-title":"Psychological and psychosocial interventions for treatment-resistant schizophrenia: a systematic review and network meta-analysis","volume":"11","author":"Salahuddin","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103583","article-title":"Non-invasive brain stimulation augmentation therapy for treatment-resistant schizophrenia: a systematic review and network meta-analysis","volume":"89","author":"Wei","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.eclinm.2026.103988_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2026.103988_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00406-023-01654-2","article-title":"A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia","volume":"274","author":"Dong","year":"2024","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.eclinm.2026.103988_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jrsm.1195","article-title":"GetReal in network meta-analysis: a review of the methodology","volume":"7","author":"Efthimiou","year":"2016","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.eclinm.2026.103988_bib13","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S2215-0366(22)00304-2","article-title":"The response of subgroups of patients with schizophrenia to different antipsychotic drugs: a systematic review and meta-analysis","volume":"9","author":"Leucht","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/npr2.12193","article-title":"Japanese Society of Neuropsychopharmacology: \u201cGuideline for pharmacological therapy of schizophrenia\u201d","volume":"41","year":"2021","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.eclinm.2026.103988_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00115-019-00813-y","article-title":"Die aktualisierte S3-Leitlinie Schizophrenie","volume":"91","author":"Hasan","year":"2020","journal-title":"Nervenarzt"},{"key":"10.1016\/j.eclinm.2026.103988_bib17","article-title":"Schizophrenia: US approves first new treatment in decades","volume":"386","author":"Torjesen","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.103988_bib18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2165\/00003495-199040050-00007","article-title":"Clozapine","volume":"40","author":"Fitton","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.eclinm.2026.103988_bib19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.schres.2007.09.006","article-title":"Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI","volume":"98","author":"Levine","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.eclinm.2026.103988_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2026.103988_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/schizbullopen\/sgaa061","article-title":"Cochrane Schizophrenia Group's study-based register of randomized controlled trials: development and content analysis","volume":"1","author":"Shokraneh","year":"2020","journal-title":"Schizophr Bull Open"},{"key":"10.1016\/j.eclinm.2026.103988_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f707","article-title":"Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment","volume":"346","author":"Panagiotou","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.103988_bib23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12874-018-0554-2","article-title":"Quality of randomized controlled trials of new generation antidepressants and antipsychotics identified in the China National Knowledge Infrastructure (CNKI): a literature and telephone interview study","volume":"18","author":"Tong","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.eclinm.2026.103988_bib24","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.103988_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.eclinm.2026.103988_bib26","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1002\/sim.6001","article-title":"Visualizing the flow of evidence in network meta-analysis and characterizing mixed treatment comparisons","volume":"32","author":"K\u00f6nig","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.eclinm.2026.103988_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.eclinm.2026.103988_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jrsm.1428","article-title":"The Kilim plot: a tool for visualizing network meta-analysis results for multiple outcomes","volume":"12","author":"Seo","year":"2021","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.eclinm.2026.103988_bib29","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/sim.6381","article-title":"Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis","volume":"34","author":"Turner","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.eclinm.2026.103988_bib30","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/aje\/kwp014","article-title":"Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease","volume":"169","author":"Welton","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eclinm.2026.103988_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.eclinm.2026.103988_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/136515002753724117","article-title":"Is olanzapine better than haloperidol in resistant schizophrenia? A double-blind study in partial responders","volume":"6","author":"Altamura","year":"2002","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.eclinm.2026.103988_bib33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/JCP.0b013e3182977308","article-title":"High-Dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms","volume":"33","author":"Goff","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.eclinm.2026.103988_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1192\/bjp.bp.106.021386","article-title":"Group cognitive-behavioural therapy for schizophrenia","volume":"189","author":"Barrowclough","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13643-024-02585-2","article-title":"Non-invasive brain stimulation for treatment-resistant schizophrenia: protocol of a systematic review and network meta-analysis","volume":"13","author":"Siafis","year":"2024","journal-title":"Syst Rev"},{"key":"10.1016\/j.eclinm.2026.103988_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/wps.20387","article-title":"Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis","volume":"16","author":"Galling","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jamapsychiatry.2018.4320","article-title":"Association of antipsychotic polypharmacy vs monotherapy with psychiatric rehospitalization among adults with schizophrenia","volume":"76","author":"Tiihonen","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.20220446","article-title":"Safety of antipsychotic polypharmacy versus monotherapy in a nationwide cohort of 61,889 patients with schizophrenia","volume":"180","author":"Taipale","year":"2023","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib40","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2026.103988_bib41","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4088\/JCP.v69n0505","article-title":"Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-Week, randomized, Double-Blind, placebo-controlled trial","volume":"69","author":"Chang","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib42","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4088\/JCP.09m05154yel","article-title":"A multicenter, randomized, Double-Blind, Placebo-Controlled, 16-Week Study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy","volume":"70","author":"Kane","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.103988_bib44","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jclinepi.2004.02.018","article-title":"Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time","volume":"57","author":"Trikalinos","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2026.103988_bib45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1176\/appi.ajp.2014.13060787","article-title":"Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study","volume":"172","author":"Petrides","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2022.103375","article-title":"Pharmacological and nonpharmacological augmentation treatments for clozapine-resistant schizophrenia: a systematic review and network meta-analysis with normalized entropy assessment","volume":"79","author":"Yeh","year":"2023","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.eclinm.2026.103988_bib47","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","article-title":"Real-World effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia","volume":"74","author":"Tiihonen","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S2215-0366(25)00001-X","article-title":"Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysis","volume":"12","author":"Schneider-Thoma","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib49","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib50","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/schbul\/sbac027","article-title":"Comparison of acute followed by maintenance ECT vs clozapine on psychopathology and regional cerebral blood flow in treatment-resistant schizophrenia: a randomized controlled trial","volume":"48","author":"Mishra","year":"2022","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.eclinm.2026.103988_bib52","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2019.19010034","article-title":"Dose-Response meta-analysis of antipsychotic drugs for acute schizophrenia","volume":"177","author":"Leucht","year":"2020","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2026.103847","article-title":"Antipsychotic dose and efficacy for acute schizophrenia spectrum disorders: an updated systematic review and dose-response meta-analysis","volume":"94","author":"Furukawa","year":"2026","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.eclinm.2026.103988_bib54","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa053222","article-title":"Clozapine Alone versus clozapine and risperidone with refractory Schizophrenia","volume":"354","author":"Honer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2026.103988_bib55","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4088\/JCP.13m08351","article-title":"Clozapine and risperidone in moderately refractory schizophrenia: a 6-Month randomized double-blind comparison","volume":"77","author":"Schooler","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib56","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1038\/s41380-023-02203-y","article-title":"Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis","volume":"28","author":"Siafis","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib57","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euroneuro.2023.03.015","article-title":"Antipsychotic-induced akathisia in adults with acute schizophrenia: a systematic review and dose-response meta-analysis","volume":"72","author":"Wu","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.eclinm.2026.103988_bib58","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/schbul\/sbac001","article-title":"Antipsychotic-Induced weight gain: dose-response meta-analysis of randomized controlled trials","volume":"48","author":"Wu","year":"2022","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.eclinm.2026.103988_bib59","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s40263-025-01218-z","article-title":"Antipsychotic-Related prolactin changes: a systematic review and dose\u2013response meta-analysis","volume":"39","author":"Lin","year":"2025","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eclinm.2026.103988_bib60","first-page":"185","article-title":"Clozapine vs haloperidol therapy in elderly chronic schizophrenic inpatients - preliminary results. A double-blind, cross-over randomized study","volume":"1","author":"Salganik","year":"1998","journal-title":"Int J Geriatr Psychopharmacol"},{"key":"10.1016\/j.eclinm.2026.103988_bib61","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1017\/S2045796025000095","article-title":"Self-reports vs clinician ratings of efficacies of psychotherapies for depression: a meta-analysis of randomized trials","volume":"34","author":"Miguel","year":"2025","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.eclinm.2026.103988_bib62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/acps.12275","article-title":"Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis","volume":"130","author":"Furukawa","year":"2014","journal-title":"Acta Psychiat Scand"},{"key":"10.1016\/j.eclinm.2026.103988_bib63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.schres.2022.01.001","article-title":"About the issue of including or excluding studies from China in systematic reviews","volume":"240","author":"Leucht","year":"2022","journal-title":"Schizophr Res"},{"key":"10.1016\/j.eclinm.2026.103988_bib64","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2024.0994","article-title":"Differential outcomes of placebo treatment across 9 psychiatric disorders","volume":"81","author":"Bschor","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eclinm.2026.103988_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102473","article-title":"Comprehensive evaluation of 45 augmentation drugs for schizophrenia: a network meta-analysis","volume":"69","author":"Etchecopar-Etchart","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.eclinm.2026.103988_bib66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jclinepi.2012.08.003","article-title":"PEDro's bias: summary quality scores should not be used in meta-analysis","volume":"66","author":"da Costa","year":"2013","journal-title":"J Clin Epidemiol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026002361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026002361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:26:34Z","timestamp":1791231994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026002361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":61,"alternative-id":["S2589537026002361"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103988","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next-step treatment for schizophrenia non-responsive to antipsychotics: a systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103988"}}